Patent details
92374 Product Name: Alogliptin sous toutes ses formes telles que protégées par le brevet de base
Basic Information
- Publication number:
- 92374
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP042581538
- Legal Status:
- Active
- Application number:
- 92374
- First applicant's nationality:
- Procedural language:
- French
Paediatric Extension
- SPC Extension Filing Date:
- 27/06/2024
- SPC Extension Agent Name:
- OFFICE FREYLINGER S.A.
- SPC Extension Status:
- Granted
- SPC Extension Grant Date:
- 28/07/2025
- SPC Extension Rejection Date:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/13/844 Vipidia - alogliptin
- Marketing Authorization Type:
- Marketing Authorization Date:
- 23/09/2013
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 12/02/2014
- First Marketing Authorization date:
- 23/09/2013
- Grant date:
- 02/11/2015
- Activation date:
- 21/12/2024
- Publication date:
- 02/11/2015
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 23/09/2028
- SPC Extension Expiration:
- 23/03/2029
- Rejection date:
- Withdrawal date:
Owner
- From:
- 12/02/2014
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI,, OSAKA 541-0045, Japan (JP)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 12/02/2014
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- SALSBURY Jonathon S. c/o Albany Molecular Research Inc.
- Address:
- United States (US)
2
- Name:
- Feng Jun
- Address:
- United States (US)
3
- Name:
- Gwaltney II, Stephen, L.
- Address:
- United States (US)
4
- Name:
- ELDER Bruce J. c/o Albany Molecular Research Inc.
- Address:
- United States (US)
5
- Name:
- Stafford Jeffrey A.
- Address:
- United States (US)
6
- Name:
- PALMER,Grant J. c/o Albany Molecular Research Inc.
- Address:
- United States (US)
7
- Name:
- ULYSEE Luckner G. c/o Albany Molecular Research Inc.
- Address:
- United States (US)
8
- Name:
- ISBESTER Paul K. c/o Albany Molecular Research Inc.
- Address:
- United States (US)
9
- Name:
- Zhang Zhiyuan
- Address:
- United States (US)
Publication
Bulletin
1
- Bulletin Heading:
- SPCX1
- Bulletin edition number:
- 2024/09
- Publication date:
- 11/07/2024
- Description:
- Section G : Applications for extensions for pediatric use – I1E publication
2
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
3
- Bulletin Heading:
- SPCX2
- Bulletin edition number:
- 2025/09
- Publication date:
- 05/08/2025
- Description:
- Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication
Annual Fees
- Annual Fee Due Date:
- 31/12/2026
- Annual Fee Number:
- 23
- Annual Fee Amount:
- 430 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 19/11/2025
- Last Annual Fee Paid Number:
- 22
- Last Annual Fee Paid Amount:
- 420 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date | Document type | Number of pages |
|---|---|---|
| 01/08/2025 | Outgoing Correspondence | 1 |
| 07/08/2025 | Certificate | 1 |
| 07/08/2025 | Publication | 1 |
| 27/06/2024 | Paediatric investigation plan | 1 |
| 27/06/2024 | Summary of the product caracteristics | 44 |
| 27/06/2024 | Application Form | 3 |
| 27/06/2024 | Marketing authorization | 3 |
| 27/06/2024 | General Document | 2 |
| 27/06/2024 | FNET_DC_FRONTPAGE | 1 |
| 27/06/2024 | Publication | 1 |
| 27/06/2024 | Outgoing Correspondence | 1 |